In January 2022, the Food and Drug Administration (FDA) issued a warning related to dental problems caused by buprenorphine when administered by dissolving in the mouth. This warning follows reports ...

Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe ...

Ever since fentanyl came to dominate the U.S. illicit drug supply, doctors and patients have found buprenorphine, a key addiction-treatment medication, increasingly difficult to use. All too often, ...

Suboxone (buprenorphine/naloxone) is a prescription drug that treats opioid use disorder in adults. Suboxone comes as a film that dissolves in your mouth. It’s usually taken once per day. Treatment ...

A seven-day, extended-release version of buprenorphine — a treatment for opioid use disorder (OUD) that can reduce opioid use and overdose deaths — is safe and effective for people with OUD ...

Suboxone is a combination of two drugs, buprenorphine and naloxone, that treats opioid use disorder (OUD). OUD is a real medical condition, just like diabetes or cancer, and is not anyone’s fault.

Response to buprenorphine among emergency department (ED) patients using fentanyl was similar to that in patients using other opioids, based on data from nearly 900 individuals. California emergency ...

Precipitated withdrawal may result from starting certain medications to treat opioid use disorder (OUD) too soon after using opioids. Typically, withdrawal symptoms occur when a person stops using ...